Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
ORIC Pharmaceuticals, Inc. Income Statement Banner

ORIC Pharmaceuticals, Inc. Income Statement

ORIC Stock Analysis

Page title

Section title

Breakdown
2017
2018
2019
2020
2021
2022
2023
Total Revenue
0.0000.0000.0000.0000.0000.0000.000
Cost of Revenue
900.000K900.000K1.000M970.000K897.000K966.000K1.032M
Gross Profit
-900.000k-900.000k-1.000m-970.000k-897.000k-966.000k-1.032m
Operating Expense
21.641M22.371M28.569M49.343M78.871M86.767M109.748M
Operating Income
-22.541m-22.371m-28.569m-74.186m-78.871m-91.767m-110.780m
Other Income Expense
0.000233.000K289.000K177.000K15.000K5.000M0.000
Total Other Income Expense
512.000K233.000K1.686M483.000K156.000K2.645M10.083M
Pretax Income
-22.029m-21.363m-26.883m-73.703m-78.715m-89.122m-100.697m
Tax Provision
0.000-1.008m-1.397m23.567M-1.038m2.355M0.000
Net Income
-22.029m-21.363m-25.486m-97.270m-77.677m-91.477m-100.697m
Basic EPS
-0.740-1.120-0.850-4.430-2.050-2.310-1.960
Diluted EPS
-0.740-1.120-0.850-4.430-2.050-2.310-1.960
Basic Average Shares
29.903M19.141M29.903M21.942M37.954M39.655M51.451M
Diluted Average Shares
29.903M19.141M29.903M21.942M37.954M39.655M51.451M
Total Expenses
22.541M22.371M28.569M49.343M78.871M86.767M110.780M
Interest Income
251.000K775.000K1.397M306.000K141.000K2.645M10.083M
Interest Expense
0.000-1.008m0.0000.0000.0002.645M0.000
EBITDA
-21.641m-21.468m-27.541m-24.500m-78.871m-81.767m-109.748m
Depreciation & Amortization
900.000K900.000K1.000M970.000K897.000K966.000K1.032M